Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AB, accuracy, ACME, advice, Alder, analytical, anniversary, Annora, anticompetitive, apremilast, atypical, autoinjector, AVSOLATM, backup, BAFF, Behcet, BeiGene, BioPharma, blocker, Blue, Brexit, bundled, buyer, CANDOR, Canyon, Castillo, celebrate, Celgene, Cesar, CGRP, chosen, Cleveland, cloud, cofounder, complement, comprised, conjugate, consortium, contemplate, contractile, contrast, convenience, costimulatory, Council, cured, curently, curiae, DARZALEX, deposit, disconnect, DOJ, door, downstream, DRL, eculizumab, ejection, embedded, eptinezumab, estate, evidentiary, exploring, EY, fast, formatted, fraction, Fraternal, gastric, GDPR, genital, Glenmark, griffith, hemoglobinuria, hemolytic, HFrEF, HHS, highest, HMO, homolog, immunogenicity, implicit, improperly, Indemnity, inflation, Inline, insufficient, insulin, interact, interactive, interval, intervenor, intervention, invention, Irrevocable, judgement, Kashiv, Kinney, Kirsten, KPH, lending, library, Lodge, lone, lookback, lymphocyte, lymphocytic, Maine, male, Mankind, Mayor, MDL, Miami, misrepresentation, MN, Momenta, MRD, MSP, multidistrict, mutation, myotrope, NaN, nearest, negligent, newest, nocturnal, NSCLC, nuclear, Nuevolution, obstructive, Officerand, oncogene, opposed, Orange, Otezla, otezla®, outage, overnight, overpaid, oversaw, overturned, overturning, panel, paroxysmal, path, payor, penalize, perspective, peter, petitioner, Pharmascience, phosphodiesterase, Pipe, platform, play, PNH, preemptive, preferential, preliminarily, prespecified, presumptively, Prinston, proceeding, prolonged, pulmonary, rat, real, refine, reply, rescheduled, restraining, revert, role, Rozibafusp, Run, Samsung, sarcoma, Scandinavian, sequencing, Sherwood, Shield, Shilpa, Slate, slated, sponte, St, stake, standing, stimulator, stressed, sua, sublease, successor, summer, SureClick, SwissBioSim, tableting, Tanvex, TDAPA, thicket, thrombocytopenia, thrombopoietin, UFCW, unanimously, unconstitutional, Unichem, unopposed, unrest, upholding, uremic, USPTO, vehicle, vendor, viral, waived, Wedbush, workforce
Removed:
ABB, accreted, Africa, African, aggregating, agile, attempting, automotive, Barr, BiTE, bortezomib, brand, Brazil, Cambridge, clarifying, compliant, composition, concluding, confronted, construct, coronary, darbepoetin, deadline, debated, declining, deliberately, disclosing, disposed, diversion, Donald, eligibility, ENDEAVOR, erythropoietin, ESPO, exchanged, excluding, exerting, frank, Friedrichshafen, fusion, gave, granting, herringer, improving, inclined, influence, infrastructure, insignificant, Insulet, integration, Lek, lengthen, lifecycle, lift, LUMICEF, Mexico, mid, monotherapy, North, occupy, older, Philadelphia, premium, preserving, prospectively, purifying, qualification, randomized, ranged, reallocate, recombinant, recommending, reinstated, reinvested, reliable, removing, renal, repealing, residential, ROMIPLATE, sBLA, separation, serving, sham, Sherman, sponsor, statute, subset, suspended, switching, TOWER, transformation, Trump, TRW, undistributed, vacated, variation, venture, vertically, withholding, Zealand, ZF
Filing tables
Filing exhibits
- 10-K Annual report
- 2.3 Amendment to No. 2 to the Asset Purchase Agreement Between Amgen and Celgene
- 2.4 Letter Agreement - Treatment of Certain Product Inventory
- 4.29 Description of Securities
- 10.4 Form of Grant of Stock Option Agreement
- 10.5 Form of Restricted Stock Unit Agreement
- 10.7 Form of Performance Unit Agreement
- 10.8 Director Equity Incentive Program
- 10.10 Form of Restricted Stock Unit Agreement
- 10.11 Form of Cash-settled Restricted Stock Unit Agreement
- 10.14 Second Amendment to Supplemental Retirement Plan
- 10.21 Second Amendment to Nonqualified Deferred Compensation Plan
- 10.41 Collaboration Agreement
- 10.42 Guarantee Agreement
- 21 Subsidiaries of the Company
- 31 Rule 13A-14(A) Certifications
- 32 Section 1350 Certifications
- Download Excel data file
- View Excel data file
Related press release
Associated AMGN transcripts
AMGN similar filings
Filing view
External links
SECOND AMENDMENT TO THE
AMGEN NONQUALIFIED DEFERRED COMPENSATION PLAN
AS AMENDED AND RESTATED EFFECTIVE OCTOBER 16, 2013
The Amgen Nonqualified Deferred Compensation Plan, as Amended and Restated Effective October 16, 2013 (the “Plan”), is hereby amended, effective January 1, 2020, as follows:
1. | Section 3.1(d) is deleted in its entirety. |
2. | Section 8.5 is amended by deleting the fourth sentence thereof and replacing it with the following: |
In addition, if the petition for payout is approved, the Participant’s deferrals for the remainder of the Plan Year shall be canceled effective as of the date of such approval. Any deferral for a subsequent Plan Year must be made in accordance with Section 3.2.
To record this Second Amendment to the Plan as set forth herein, the Company has caused its authorized officer to execute this document this 23rd day of October, 2019.
AMGEN INC.
By: | /s/ Lori A. Johnston |
Name: Lori A. Johnston Title: Executive Vice President, Human Resources |